Martingale Asset Management’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,525
Closed -$309K 767
2024
Q3
$309K Hold
12,525
0.01% 707
2024
Q2
$317K Buy
12,525
+1
+0% +$26 0.01% 685
2024
Q1
$318K Hold
12,524
0.01% 700
2023
Q4
$284K Sell
12,524
-4
-0% -$83 0.01% 712
2023
Q3
$233K Sell
12,528
-1,170
-9% -$24.3K ﹤0.01% 725
2023
Q2
$356K Buy
13,698
+1,776
+15% +$47.5K 0.01% 672
2023
Q1
$342K Buy
+11,922
New +$355K 0.01% 688
2014
Q3
Sell
-8,155
Closed -$378K 848
2014
Q2
$378K Sell
8,155
-8,352
-51% -$371K 0.01% 743
2014
Q1
$679K Buy
16,507
+1
+0% +$37 0.02% 612
2013
Q4
$630K Buy
16,506
+2,202
+15% +$67.9K 0.02% 699
2013
Q3
$342K Buy
+14,304
New +$321K 0.01% 852

Other funds holding ANIK